The virus has now appeared where it never was before
Once before, mpox crossed oceans and unsettled the world; now a more dangerous descendant of that virus is moving through central and eastern Africa with greater speed and lethality, compelling the World Health Organization to weigh its highest alarm. Since September 2023, a new subvariant known as Ib has spread from the Democratic Republic of Congo into countries where mpox had never before taken root, leaving 14,000 confirmed cases and 511 deaths in its wake. The question before an emergency committee of independent experts is whether this moment demands the kind of coordinated global response that only a formal declaration of international concern can unlock — and whether the lessons of 2022 were learned well enough to matter now.
- A newly aggressive mpox subvariant, more transmissible and more lethal than its predecessors, has broken out of the DRC and crossed into Burundi, Kenya, Rwanda, and Uganda — territories the virus had never previously reached.
- In just the first half of 2024, the DRC recorded as many cases as in all of 2023, signaling a virus accelerating beyond the pace of containment efforts.
- The WHO director-general has called an emergency committee to determine whether to issue one of the organization's highest alerts, a declaration that would trigger coordinated international response protocols.
- Spain, still carrying incomplete vaccination coverage from the 2022 outbreak — only half of those vaccinated received the full course — is now urging at-risk populations to complete their regimens before the aggressive African variant arrives.
- The world's health systems face a direct test of institutional memory: the infrastructure and political will built during the 2022 crisis must now prove it can mobilize faster than a virus already moving faster than expected.
The World Health Organization is preparing to convene an emergency committee to decide whether to declare a global health emergency over mpox — a virus that has alarmed the world before and now threatens to do so again in a more dangerous form. The trigger is a newly aggressive subvariant, known as Ib, which has spread rapidly through the Democratic Republic of Congo since September 2023 and begun crossing into neighboring countries where mpox had never previously established itself, including Burundi, Kenya, Rwanda, and Uganda.
WHO director-general Tedros Adhanom Ghebreyesus announced that independent experts would convene as soon as possible to assess whether the outbreak rises to the level of a public health emergency of international concern — one of the organization's highest alerts, capable of triggering coordinated emergency responses governed by international health regulations. The numbers are stark: 14,000 confirmed cases and 511 deaths, with the first half of 2024 alone producing as many cases as all of 2023.
This is not mpox's first global moment. In 2022, a less lethal variant spread from Africa to Europe and the Americas, producing roughly 90,000 cases and 140 deaths before the emergency was lifted in May 2023. Spain was among the hardest hit, recording 8,101 infections, though its vaccination campaign reached only partial completion — of more than 40,000 people vaccinated, just half received the full course of doses. Spain's health ministry is now urging at-risk populations to complete their regimens, even as the country has so far identified no cases of the more aggressive African subvariant among its 247 new infections this year.
The virus spreads through close contact — sexual, domestic, or clinical — and has circulated in human populations since 1970. Vaccination remains the most reliable defense; the smallpox vaccine, which eradicated that disease by 1979, also confers protection against mpox. The current outbreak is a test of whether the world's health systems absorbed the lessons of two years ago, and whether they can move quickly enough to contain a virus that has already demonstrated it can outpace them.
The World Health Organization is preparing to convene an emergency committee to decide whether to declare a global health emergency over mpox, a virus that has circled the world before and now threatens to do so again—this time in a more dangerous form. The decision comes as a newly aggressive variant of the virus, known as subclado Ib, has torn through the Democratic Republic of Congo since September 2023 and begun spreading into neighboring countries where mpox had never taken hold before.
Tedros Adhanom Ghebreyesus, the WHO's director-general, announced that independent experts from multiple disciplines would convene as soon as possible to assess whether the outbreak constitutes a public health emergency of international concern—one of the highest alerts the organization can issue. Such a declaration would trigger coordinated emergency responses across countries worldwide, governed by international health regulations designed to slow transmission.
The numbers tell the story of a virus moving with unusual speed and lethality. In the first six months of 2024 alone, the Democratic Republic of Congo recorded as many cases as it had in the entirety of 2023. As of the announcement, health authorities had documented 14,000 confirmed cases and 511 deaths across the affected region. What makes this outbreak distinct is not just its scale but its reach: the virus has now appeared in Burundi, Kenya, Rwanda, and Uganda—territories where mpox had never previously established itself. The subclado Ib variant shows both greater transmissibility and higher mortality than its predecessors.
This is not the first time mpox has alarmed global health authorities. Two years earlier, in 2022, a less aggressive variant jumped from Africa to the United Kingdom and ignited outbreaks across Europe and North America, with Spain hit particularly hard. That outbreak, driven primarily by transmission among men who have sex with men, produced roughly 90,000 cases and 140 deaths worldwide before the emergency declaration was lifted in May 2023. Spain alone recorded 8,101 confirmed infections, though vaccination campaigns there reached only partial completion—of the 40,610 people vaccinated, just half received the full course of doses.
The disease itself is recognizable by fever, muscle pain, and distinctive skin lesions that spread across the body. Transmission requires close contact: sexual contact, shared living space, or exposure in healthcare settings. The virus has circulated in human populations since 1970, when it was first identified in the Democratic Republic of Congo. Two main variants had been known for decades—a more lethal strain endemic to central Africa and a milder one from the west—but the current subclado Ib represents a particularly concerning hybrid.
Vaccination offers the most reliable defense. The smallpox vaccine, which was deployed worldwide and helped eradicate that disease in 1979, also protects against mpox. People vaccinated against human smallpox in childhood carry immunity to the monkey virus as well. Spain's health ministry has now urged people to complete their vaccination regimens, particularly those with multiple sexual partners or those who have had close contact with confirmed cases. As of this year, Spain has identified 247 new mpox cases, the vast majority in men with an average age of 37, but none yet carrying the more aggressive African variant.
The WHO maintains a watch list of more than fifty pathogens deemed capable of triggering pandemics, and mpox has earned its place through repeated demonstration of its ability to cross borders and establish itself in new populations. The current outbreak represents a test of whether the world's health systems have learned from 2022, and whether vaccination infrastructure can be mobilized quickly enough to contain a virus that has already shown it can move faster than expected.
Citações Notáveis
The committee will meet as soon as possible and will be composed of independent experts from various relevant disciplines around the world— WHO Director-General Tedros Adhanom Ghebreyesus
Spain's health ministry emphasized the importance of completing the full vaccination regimen, particularly for people with multiple sexual partners and those with close contact to confirmed cases— Spanish Ministry of Health
A Conversa do Hearth Outra perspectiva sobre a história
Why is the WHO considering a new emergency declaration now, when they already lifted one just last year?
Because this isn't the same virus. The variant circulating now—subclado Ib—is more lethal and more transmissible than what we saw in 2022. It's also spreading into parts of Africa where mpox had never established itself before. That's the signal that something has shifted.
What's the practical difference between declaring an emergency and not declaring one?
An emergency declaration triggers coordinated responses across countries—vaccination campaigns, surveillance protocols, resource allocation. Without it, each country responds on its own timeline, which is slower and less coordinated. The virus doesn't wait for bureaucracy.
Spain had 8,000 cases in 2022 but only 247 this year. Why the dramatic drop?
Partly because immunity built up from the 2022 outbreak, partly because people became more cautious about transmission routes. But also because the variant circulating then was less aggressive. The real test is whether Spain's vaccination rate is high enough to stop the new variant if it arrives.
Only half the people vaccinated in Spain completed their full course. That seems like a problem.
It is. You need the complete regimen for full protection. Partial vaccination leaves gaps, especially against a more aggressive variant. That's why the health ministry is now pushing people to finish what they started.
How does this variant differ genetically from the ones we saw before?
The source material doesn't detail the genetic differences, but the epidemiology tells us what matters: it's spreading faster, killing more people, and establishing itself in new geographic areas. Those are the signatures of a virus that's evolved in ways that make it more dangerous.
What happens if the WHO declares the emergency?
Governments activate pandemic protocols—faster vaccine distribution, border screening, coordinated public health messaging. It's the difference between a controlled response and a reactive one. The question is whether they act fast enough.